Vor Biopharma Inc.

VOR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$81,949$31,360$57,706$119,801
Short-Term Investments$9,977$105,815$172,539$87,668
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,581$3,628$6,705$6,930
Total Curr. Assets$96,507$140,803$236,950$214,399
Property Plant & Equip (Net)$41,588$50,098$57,078$22,523
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$2,413$2,413$0
Tax Assets$0$11,702$0$0
Other NC Assets$4,796$4,812$2,925$5,668
Total NC Assets$46,384$69,025$62,416$28,191
Other Assets$0$0$0$0
Total Assets$142,891$209,828$299,366$242,590
Liabilities
Payables$1,505$815$1,772$1,545
Short-Term Debt$4,215$3,830$3,272$1,839
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$12,892$10,927$8,075$6,769
Total Curr. Liab.$18,612$15,572$13,119$10,153
LT Debt$27,615$31,830$35,640$16,174
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$11,702$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$27,615$43,532$35,640$16,174
Other Liabilities$0$0$0$0
Cap. Leases$31,830$31,830$38,912$18,013
Total Liabilities$46,227$59,104$48,759$26,327
Equity
Pref Stock$0$0$0$0
Common Stock$13$7$7$4
Retained Earnings-$456,994-$340,080-$222,217-$130,122
AOCI$22-$77-$770$0
Other Equity$553,623$490,874$473,587$346,381
Total Equity$96,664$150,724$250,607$216,263
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$142,891$209,828$299,366$242,590
Net Debt-$50,119$4,300-$18,794-$101,788